Alumni raised $1.45B in 2022 - Download Free Report Now

Rosetta Genomics (NASDAQ: ROSG)

Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and....

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Rosetta Genomics (NASDAQ: ROSG) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Rosetta Genomics (NASDAQ: ROSG)

Technology/product details

CEO presentation

Competing Startups


Companies We Work With